Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02038140 · ClinicalTrials.gov registry record · NA
Zimmer Trabecular Metal Total Ankle PMCF
A NA study of Rheumatoid Arthritis and Post Traumatic Arthritis, sponsored by Zimmer Biomet.
- Active
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 11
- Study locations
NCT02038140: Active NA study of Rheumatoid Arthritis and Post Traumatic Arthritis, sponsored by Zimmer Biomet.
NCT02038140 is a NA study of Rheumatoid Arthritis and Post Traumatic Arthritis that is active but no longer recruiting, run by Zimmer Biomet. The registered enrollment target is 120 participants, below the 4,690-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (97% lower). The trial reports 11 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02038140, a NA study of Rheumatoid Arthritis and Post Traumatic Arthritis, is active but no longer recruiting, sponsored by Zimmer Biomet.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 11
- Study locations
Study Summary
The primary objective of this study is to obtain implant survivorship and clinical outcome data for commercially available Zimmer Trabecular Metal Total Ankle implants used in primary or revision total ankle arthroplasty. The assessment will include implant survivorship and clinical performance measured by pain and function, quality of life data, radiographic parameters and survivorship.
Primary Outcome
Survival of the implants after 10 years which is based on removal of the prosthesis and will be determined using the Kaplan Meier Method.
Conditions Studied
Interventions
- DEVICE Zimmer Trabecular Metal Total Ankle System
Study Locations (11)
Other
- Turku University Hospital Finland - Turku
- Klinikverbund St. Antonius und St. Josef GmbH - Wuppertal
- Inselspital-Stiftung Universitatsspital Bern - Bern
- Spital StS AG - Thun
North Carolina
- OrthoCarolina Research Institute - Charlotte
- Duke University - Durham
California
- University California Davis - Sacramento
Michigan
- Orthopaedic Associates of Grand Rapids REI - Grand Rapids
Pennsylvania
- The Rothman Institute - Philadelphia
British Columbia
- UBC Providence Health Care Research Institute - Vancouver
Milano MI
- Humanitas San Pio X - Milan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2014-03 |
| Est. Completion | 2027-03 |
| Phase | NA |
What the registry record for NCT02038140 still lists
NCT02038140 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 4,690-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (97% lower).
The record links to 3 conditions, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 1 intervention - of which Zimmer Trabecular Metal Total Ankle System is the first listed.
NCT02038140 lists 11 locations in 7 states (Other, North Carolina, California).
Frequently Asked Questions
What is clinical trial NCT02038140 about?
NCT02038140 is a clinical study titled "Zimmer Trabecular Metal Total Ankle PMCF". The primary objective of this study is to obtain implant survivorship and clinical outcome data for commercially available Zimmer Trabecular Metal Total Ankle implants used in primary or revision total ankle arthroplasty. The assessment will include implant survivorship and clinical performance meas...
What is the current status of trial NCT02038140?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2014-03. Estimated completion is 2027-03.
What conditions does trial NCT02038140 study?
This clinical trial studies the following conditions: Rheumatoid Arthritis, Post Traumatic Arthritis, Degenerative Arthritis.
What interventions are being tested in trial NCT02038140?
The interventions under investigation include: Zimmer Trabecular Metal Total Ankle System (DEVICE).
Who is sponsoring clinical trial NCT02038140?
This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02038140 being conducted?
This trial has 11 study locations across California, Michigan, North Carolina, Pennsylvania, British Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rheumatoid Arthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02038140's enrollment target sits among peer trials
120 110th of 197 higher than 87 of 197 other Rheumatoid Arthritis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Rheumatoid Arthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))
RECRUITING · NA
-
Creating Health Course Study for People With Rheumatological Conditions
RECRUITING · NA
-
Physica System Total Knee Replacement Registry Study
RECRUITING · NA
-
Targeted Remotely-delivered Anti-inflammatory Interventions With Exercise for Rheumatoid Arthritis
RECRUITING · NA
-
Improving Hypertension Control in Rheumatoid Arthritis
RECRUITING · NA
-
Effect of Anti-inflammatory Diet in Rheumatoid Arthritis
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia